It may not be a war cry yet, but the voice is definitely getting shriller.
The last week of October and the next two weeks will see many more movie hits in DVD and, in most cases, Blu-ray versions.
Most pharma stocks are trading at the higher end of their valuations and thus investors need to practice utmost caution.
From thousands of job losses to historic bankruptcies to Dubai debt crisis, the year had more than its share of shocks.
Let us see why the pharma index is valued at a premium by the market and why some companies are valued higher than others.
When the votes for the Reader's Choice CEO of the Year by MarketWatch were counted, Dr Ramesh Pandey of Xechem came first, beating Steve Jobs of Apple and Warren Buffett of Berkshire.
Ranked here are companies (on the basis of operating margin and return on net worth) in FY94 and in FY04 to understand the change in dynamics.
Saina Nehwal beat Scotland's Susan Egelstaf on Tuesday, to book a spot in the final of the badminton event in the Commonwealth Games.
Asian gold medallist Suranjoy Singh (52kg) and Amandeep Singh (49kg) advanced to the quarter-finals, while defending champion Akhil Kumar (56kg) booked a place in the last-16 stage in front of a rapturous home crowd at the Talkatora stadium on Thursday.
The two 30-year-olds co-founded what they described was the next generation online shopping engine focusing on true price discovery and unparalleled consumer benefits.
A portfolio of stocks designed on the basis of Benjamin Graham's principles has beaten the market over the past three years.
The Sensex finally closed 19 points lower at 5,758. The Nifty moved in a range of 1,825 - 1,813, before settling with a marginal loss of two points at 1,818.
The Nifty ended three points lower at 1,723.\n\n
Prev |